Francis Collins

Guest lineups for the Sunday news shows

Virus researchers, integration leader among NC Award winners

RALEIGH, N.C. (AP) — Developers of COVID-19 treatments, a champion of public school integration, a folk musician and authors are among the nine latest recipients of North Carolina’s highest civilian honor.

Guest lineups for the Sunday news shows

Top infectious disease expert Dr. Anthony Fauci responds to accusations by Sen. Rand Paul, R-Ky., as he testifies before the Senate Health, Education, Labor, and Pensions Committee, on Capitol Hill in Washington, Tuesday, July 20, 2021. Cases of COVID-19 have tripled over the past three weeks, and hospitalizations and deaths are rising among unvaccinated people. (AP Photo/J. Scott Applewhite, Pool)

Man charged with sending threatening emails to Dr. Fauci

Federal prosecutors in Maryland say a man has been arrested and charged with sending emails that threatened to harm and kill Dr.

Guest lineups for the Sunday news shows

Rachel Van Lear poses for a portrait at her home in Buda, Texas, Tuesday, March 9, 2021. Van Lear says she was in great shape when she got sick. At 35, she had no underlying illnesses and was a busy mother of three who often worked out. First came a chest cold, then a high fever. A flu test came back negative, so her doctor tested for COVID-19. Results were positive. Soon after she developed blinding headaches, debilitating fatigue and nausea so severe that she needed ER treatment to replace fluid. (AP Photo/Eric Gay)

Survivors struggle as scientists race to solve COVID mystery

There was no reason to celebrate on Rachel Van Lear’s anniversary. The same day a global pandemic was declared, she developed symptoms of COVID-19.

FILE - This July 2020 photo provided by Johnson & Johnson shows a vial of the COVID-19 vaccine in Belgium. The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday, Feb. 27, 2021 cleared a Johnson & Johnson shot that works with just one dose instead of two.(Johnson & Johnson via AP, File)

J&J’s 1-dose shot cleared, giving US 3rd COVID-19 vaccine

WASHINGTON (AP) — The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two.

People check in at a food bank held at Los Angeles Boys & Girls Club in the Lincoln Heights neighborhood of Los Angeles, Thursday, Dec. 17, 2020. "This neighborhood is hard hit by COVID-19. Our families work in service industry jobs," said Carlyn Oropez, director of operations at the facility. "Most of the people here have had reduction in hours, reduction in pay, or have lost their jobs. They are coming here for help with basic needs." (AP Photo/Jae C. Hong)

US clears Moderna vaccine for COVID-19, 2nd shot in arsenal

WASHINGTON (AP) — The U.S. added a second COVID-19 vaccine to its arsenal Friday, boosting efforts to beat back an outbreak so dire that the nation is regularly recording more than 3,000 deaths a day.

Guest lineups for the Sunday news shows

WASHINGTON (AP) — Guest lineups for the Sunday news shows:

ABC’s “This Week” — Food and Drug Administration Commissioner Stephen Hahn; Gov.

Dr. Francis Collins, Director of the National Institutes of Health, gives an opening statement during a Senate Health, Education, Labor and Pensions Committee hearing to discuss vaccines and protecting public health during the coronavirus pandemic on Capitol Hill, Wednesday, Sept. 9, 2020, in Washington. (Greg Nash/Pool via AP)

Vaccine by Nov. 3? Halted study explains just how unlikely

WASHINGTON (AP) — The suspension of a huge COVID-19 vaccine study over an illness in a single participant shows there will be “no compromises” on safety in the race to develop the shot, the chief of the National Institutes of Health told Congress on Wednesday.

FILE - In this Monday, July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. Who gets to be first in line for a COVID-19 vaccine? U.S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it’s a vexing decision. (AP Photo/Hans Pennink)

Debate begins for who’s first in line for COVID-19 vaccine

Who gets to be first in line for a COVID-19 vaccine? U.S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it’s a vexing decision.

FILE - In this Thursday, May 7, 2020 file photo, National Institutes of Health Director Dr. Francis Collins, left, speaks with Chairman Sen. Lamar Alexander, R-Tenn., prior to a Senate Health Education Labor and Pensions Committee hearing on new coronavirus tests on Capitol Hill in Washington. Collins has lauded the majority of American faith communities for treating the pandemic as an opportunity to live out their values by helping the vulnerable. He also offered careful criticism for the “occasional examples of churches who reject the scientific conclusions and demand the right to continue to assemble freely, even in the face of evidence that this endangers their whole community.”(AP Photo/Andrew Harnik, Pool)

For top U.S. virus experts, faith and science work together

NEW YORK (AP) — The relationship between faith and science has faced its share of strain during the coronavirus pandemic — but for some scientists leading the nation’s response, the two have worked in concert.

FILE - In this May 7, 2020 file photo, National Institutes of Health Director Dr. Francis Collins attends a Senate Health Education Labor and Pensions Committee hearing on new coronavirus tests on Capitol Hill in Washington. On Wednesday, May 20, 2020, the physician and geneticist was announced as the winner of the 2020 Templeton Prize, one of the world’s leading religion prizes for demonstrating how religious faith can motivate scientific research. (AP Photo/Andrew Harnik, Pool)

Genetics expert Francis Collins wins major religion prize

Physician and geneticist Francis Collins, director of the National Institutes of Health since 2009, has been awarded one of the world’s leading religion prizes for demonstrating how religious faith can motivate scientific research.

A monitor displays video feeds from members of the Senate Health Education Labor and Pensions Committee via teleconference during a Senate Health Education Labor and Pensions Committee hearing on new coronavirus tests on Capitol Hill in Washington, Thursday, May 7, 2020. National Institutes of Health Director Dr. Francis Collins, looks on at right. (Anna Moneymaker/The New York Times via AP, Pool)

US faces ‘truly daunting’ challenges on needed COVID tests

WASHINGTON (AP) — Despite a massive effort, the nation faces “truly daunting” challenges to deploy millions of coronavirus tests to safely re-open the economy, the head of the National Institutes of Health told lawmakers Thursday.

In a milestone year, gene therapy finds a place in medicine

After decades of hope and high promise, this was the year scientists really showed they could doctor DNA to successfully treat diseases.

In this Aug. 7, 2017, photo, Kenneth Parker Ulrich, left, a research technician at the University of Pittsburgh Medical Center, inserts a needle to collect a blood sample from Erricka Hager, a participant in the "All of Us" research program in Pittsburgh. The "All of Us" research program is run by the National Institutes of Health and plans to track the health of at least 1 million volunteers by 2019. By doing so, researchers hope to learn how to better tailor treatments and preventative care to people's genes, environments, and lifestyle. The University of Pittsburgh is running a pilot program with some of the first enrollees in the study. (AP Photo/Dake Kang)

Wanted: 1 million people to study genes, habits and health

WASHINGTON (AP) — In a quest to end cookie-cutter health care, U.S. researchers are getting ready to recruit more than 1 million people for an unprecedented study to learn how our genes, environments and lifestyles interact — and to finally customize ways to prevent and treat disease.